Cancer surgery poses an elevated risk for venous thromboembolism, which can vary depending on the type of cancer and the timing of surgery, a new study suggested. "The marked variation in the ...
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) The systematic review included 35 publications on ...
Please provide your email address to receive an email when new articles are posted on . Longer vs. shorter-duration anticoagulation reduces thrombotic event risk for patients with cancer and isolated ...
Many clinical trials and meta-analyses have shown that subcutaneous injections of LMWH are comparable to continuous infusions of UFH for initial therapy; [58] however, oral vitamin K antagonists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback